Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)
Razavi AC, Reyes MP, Wilkins JT, et al.
Journal:
Eur J Prev Cardiol

First published: November 28, 2024 DOI: 10.1093/eurjpc/zwae382
View
- Share
Articles
Ezetimibe: Integrating Established Use with New Evidence – A Comprehensive Review
Olmastroni E, Scotti S, Galimberti F, et al.
Journal:
Curr Atheroscler Rep

First published: November 25, 2024 DOI: 10.1007/s11883-024-01248-w
View
- Share
Articles
Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial
Nicholls SJ, Ni W, Rhodes GM, et al.
Journal:
JAMA

First published: November 18, 2024 DOI: 10.1001/jama.2024.24017
View
- Share
Articles
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study
Patel KV, Chunawala Z, Verma S, et al.
Journal:
J Am Coll Cardiol

First published: November 15, 2024 DOI: 10.1016/j.jacc.2024.11.004
View
- Share
Articles
Lp(a): A Rapidly Evolving Therapeutic Landscape
Anchouche K, Thanassoulis G
Journal:
Curr Atheroscler Rep

First published: November 11, 2024 DOI: 10.1007/s11883-024-01252-0
View
- Share
Articles
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?
Nicholls SJ, Tan S, Butters J, et al.
Journal:
Expert Opin Pharmacother

First published: October 25, 2024 DOI: 10.1080/14656566.2024.2409324
View
- Share
Articles
LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention
Li J, Yan K, Zhu P, et al.
Journal:
Clin Cardiol

First published: October 21, 2024 DOI: 10.1002/clc.70025
View
- Share
Articles
Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial
van der Aalst CM, Denissen SJAM, Vonder M, et al.
Journal:
Eur Heart J Cardiovasc Imaging

First published: October 20, 2024 DOI: 10.1093/ehjci/jeaa168
View
- Share
Articles
Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease
Shah NP, Mulder H, Lydon B, et al.
Journal:
Am Heart J

First published: October 16, 2024 DOI: 10.1016/j.ahj.2024.10.009
View
- Share
Articles
Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation
Nicholls SJ, Manmathan GP
Journal:
Atherosclerosis

First published: October 11, 2024 DOI: 10.1016/j.atherosclerosis.2024.118628
View
- Share
Articles
Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases
Potere N, Bonaventura A, Abbate A
Journal:
Arterioscler Thromb Vasc Biol

First published: October 10, 2024 DOI: 10.1161/ATVBAHA.124.319980
View
- Share
Articles
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Carvalho PEP, Gewehr DM, Nascimento BR, et al.
Journal:
JAMA Cardiol

First published: October 9, 2024 DOI: 10.1001/jamacardio.2024.3216
View
- Share

1 2 3

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)

Razavi AC, Reyes MP, Wilkins JT, et al.

Articles

Ezetimibe: Integrating Established Use with New Evidence – A Comprehensive Review

Olmastroni E, Scotti S, Galimberti F, et al.

Articles

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial

Nicholls SJ, Ni W, Rhodes GM, et al.

Articles

Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study

Patel KV, Chunawala Z, Verma S, et al.

Articles

Lp(a): A Rapidly Evolving Therapeutic Landscape

Anchouche K, Thanassoulis G

Articles

Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?

Nicholls SJ, Tan S, Butters J, et al.

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Articles

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

van der Aalst CM, Denissen SJAM, Vonder M, et al.

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Articles

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Potere N, Bonaventura A, Abbate A

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Articles

Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)

Razavi AC, Reyes MP, Wilkins JT, et al.

Share

Articles

Ezetimibe: Integrating Established Use with New Evidence – A Comprehensive Review

Olmastroni E, Scotti S, Galimberti F, et al.

Share

Articles

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial

Nicholls SJ, Ni W, Rhodes GM, et al.

Share

Articles

Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study

Patel KV, Chunawala Z, Verma S, et al.

Share

Articles

Lp(a): A Rapidly Evolving Therapeutic Landscape

Anchouche K, Thanassoulis G

Share

Articles

Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?

Nicholls SJ, Tan S, Butters J, et al.

Share

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Share

Articles

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

van der Aalst CM, Denissen SJAM, Vonder M, et al.

Share

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Share

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Share

Articles

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases

Potere N, Bonaventura A, Abbate A

Share

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Share